PMS38 COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SC IN COMPARISON WITH ANAKINRA IN SYSTEMIC IDIOPATHIC JUVENILE ARTHRITIS (SJIA) TREATMENT IN TURKEY

Autor:	B. Tonga, E. Erdogan-Ciftci, L. Yanik, B. Akyol Ersoy
Rok vydání:	2019
Předmět:	Anakinra medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Cost-effectiveness analysis chemistry.chemical_compound Tocilizumab chemistry Internal medicine medicine business Idiopathic juvenile arthritis medicine.drug
Zdroj:	Value in Health. 22:S700
ISSN:	1098-3015
DOI:	10.1016/j.jval.2019.09.1582
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6e0b734d23e9af2e2f639a8a06778cbc https://doi.org/10.1016/j.jval.2019.09.1582 Zobrazit plný text záznamu Full Text from ScienceDirect